[1]JournalofOrganicChemistry,1984,vol.49,p.4076-4078
Title: An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562
100836-85-9
2050-25-1
30379-55-6
30379-58-9
32122-09-1
24342-68-5
945-83-5 | 2-Propoxyquinoline | AA00H5X4 | MFCD18783197
944059-24-9 | 1H-Pyrrolo[2,3-b]pyridin-5-ylboronic acid | AA00H7HX | MFCD08234881
95635-56-6 | Ranolazine dihydrochloride | AA00H8NT | MFCD03788770
100868-72-2 | Methylpyridin-2-ylmethylamine DiHCl | AA00H9AC | MFCD03840005
1019650-87-3 | 4-(3-Fluorophenyl)pyrrolidin-2-one | AA00H9ML | MFCD09955048
103323-25-7 | 3',5'-Dimethyl-2'-hydroxyacetophenone | AA00H9YT | MFCD01631133
104224-63-7 | 2-Adamantyl-4-bromoanisole | AA00HA8G | MFCD03855308
1051934-98-5 | (2S)-3-(3,5-Dichlorophenyl)-2-[(tert-butoxy)carbonylamino]propanoic acid | AA00HAIP | MFCD07372033
106449-56-3 | 2'-Deoxyisoguanosine | AA00HAQI | MFCD15145285
1082040-47-8 | (2-Bromo-4-chloro-6-nitrophenyl)acetic acid | AA00HB0K | MFCD11845449